mortality/aging
• most homozygous embryos die in utero prior to day 8 of gestation
|
Allele Symbol Allele Name Allele ID |
Apctm1Mmt targeted mutation 1, Makoto M Taketo MGI:1857957 |
||||||||||||||||||||||||||||||||||||||||||||||||
Summary |
11 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• most homozygous embryos die in utero prior to day 8 of gestation
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• intestinal polyps are polyploid, papillary, or sessile adenoma; every polyp consists of a microadenoma covered with a normal layer of villous epithelium
(J:25200)
• increase in incidence follows loss of normal Apc allele in nascent polyps
(J:25200)
• numerous intestinal tumors develop in homozygotes
(J:79668)
• most tumors are small; one animal developed a tumor >6 mm in diameter
(J:79668)
|
• intestinal polyps are polyploid, papillary, or sessile adenoma; every polyp consists of a microadenoma covered with a normal layer of villous epithelium
(J:25200)
• increase in incidence follows loss of normal Apc allele in nascent polyps
(J:25200)
• numerous intestinal tumors develop in homozygotes
(J:79668)
• most tumors are small; one animal developed a tumor >6 mm in diameter
(J:79668)
|
• multiple polyps develop soon after birth; all heterozygotes develop polyps by 7 weeks of age and numbers increase with age
• polyps are found from duodenum to rectum, mainly in small intestine
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
familial adenomatous polyposis | DOID:0050424 |
OMIM:PS175100 |
J:25200 |
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• adenocarcinomas by histopathological definition
• the extent of cellular atypia and epithelial architecture are rather similar to those in the Apctm1Mmt adenomas, without a very malignant appearance
|
• adenocarcinomas by histopathological definition
• the extent of cellular atypia and epithelial architecture are rather similar to those in the Apctm1Mmt adenomas, without a very malignant appearance
|
• treated with 4-hydroxytamoxifen to activate Cre recombinase at 3 weeks of age
• tumor invasion and intravasation into the smooth muscle layer of the small intestine and colon at 17 weeks of age
• in polyps larger than 2 mm in diameter, about half of them is found invading into the submucosa or beyond
• often seen inside vessels that are distended, reminiscent of tumor embolism
|
• adenocarcinomas by histopathological definition
• the extent of cellular atypia and epithelial architecture are rather similar to those in the Apctm1Mmt adenomas, without a very malignant appearance
|
• adenocarcinomas by histopathological definition
• the extent of cellular atypia and epithelial architecture are rather similar to those in the Apctm1Mmt adenomas, without a very malignant appearance
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• increased anaphase bridge index
• accelerated transition from G1 to S phase
• increased DNA synthesis
• lower apoptotic rates
|
• increased in numbers relative to Apctm1Mmt
• mostly in the distal colon
|
• decreased anaphase bridge index
• decreased transition from G1 to S phase
• decreased DNA synthesis
• increased apoptotic rates
• significantly reduced number of polyps relative to Apctm1Mmt
|
• increased anaphase bridge index in the large intestine and decreased in the small intestine
|
• accelerated transition from G1 to S phase in the large intestine and decreased in the small intestine
• increased DNA synthesis in the large intestine and decreased in the small intestine
|
• lower apoptotic rates in the large intestine
|
• in the small intestine
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• mice exhibit a decrease in tumors size compared to in Apctm1Mmt Smad4tm1Mmt homozygotes
• the ratio of small tumors is increased compared to in Apctm1Mmt Smad4tm1Mmt homozygotes
• however, mice exhibit the same tumor invasion depth and number of fibroblasts in tumor stroma as in Apctm1Mmt Smad4tm1Mmt homozygotes
|
• mice develop 50% fewer tumors than in Apctm1Mmt Smad4tm1Mmt homozygotes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• a small number of mice die suddenly, before thirty weeks of age, as result of lethal intestinal obstruction by large tumorous polyps
|
• numerous intestinal tumors develop in homozygotes: compound mutants have more intestinal tumors >4 mm in diameter than Apctm1Mmt heterozygotes
• frequently one or two tumors >6 mm in diameter develop
• 10-15% of intestinal polyps exhibit stromal and vascular invasion
• tubular adenomas vary in size and shape, and solid colonies of poorly differentiated carcinoma cells are sometimes observed
• nuclei display more hyperchromaticity than those in tumors in Apc single heterozygotes; nuclear atypia in tumors is enhanced indicating increased malignancy
|
• numerous intestinal tumors develop in homozygotes: compound mutants have more intestinal tumors >4 mm in diameter than Apctm1Mmt heterozygotes
• frequently one or two tumors >6 mm in diameter develop
• 10-15% of intestinal polyps exhibit stromal and vascular invasion
• tubular adenomas vary in size and shape, and solid colonies of poorly differentiated carcinoma cells are sometimes observed
• nuclei display more hyperchromaticity than those in tumors in Apc single heterozygotes; nuclear atypia in tumors is enhanced indicating increased malignancy
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• a small number of mice die suddenly, before thirty weeks of age, as result of lethal intestinal obstruction by large tumorous polyps
|
• numerous intestinal tumors develop in homozygotes: compound mutants have more intestinal tumors >4 mm in diameter than Apctm1Mmt heterozygotes
• frequently one or two tumors >6 mm in diameter develop
• 10-15% of intestinal polyps exhibit stromal and vascular invasion
• tubular adenomas vary in size and shape, and solid colonies of poorly differentiated carcinoma cells are sometimes observed
• nuclei display more hyperchromaticity than those in tumors in Apc single heterozygotes; nuclear atypia in tumors is enhanced indicating increased malignancy
|
• numerous intestinal tumors develop in homozygotes: compound mutants have more intestinal tumors >4 mm in diameter than Apctm1Mmt heterozygotes
• frequently one or two tumors >6 mm in diameter develop
• 10-15% of intestinal polyps exhibit stromal and vascular invasion
• tubular adenomas vary in size and shape, and solid colonies of poorly differentiated carcinoma cells are sometimes observed
• nuclei display more hyperchromaticity than those in tumors in Apc single heterozygotes; nuclear atypia in tumors is enhanced indicating increased malignancy
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• at 10 weeks, double heterozygotes develop only ~34% of the polyp number detected in the intestinal tracts of mice heterozygous for Apctm1Mmt alone
|
• at 10 weeks, double heterozygotes exhibit only 1.5 1.9 colonic polyps versus 6.8 7.2 detected in mice heterozygous for Apctm1Mmt alone
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• at 10 weeks, these mutants develop only ~14% of the polyp number detected in the intestinal tracts of mice heterozygous for Apctm1Mmt alone
• the size of intestinal polyps is significantly smaller (<1.0 mm) than that observed in mice heterozygous for Apctm1Mmt alone, with no polyps larger than 2.0 mm in diameter
• histologically, well-developed polyps are not covered with the normal intestinal epithelium and appear flatter than polyps found in Apctm1Mmt heterozygous controls
• notably, no colonic polyps are observed
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• most mutants become moribund before 14-20 weeks and often die of intussusception of the small intestine
|
• polyps in small and large intestine develop into malignant adenocarcinomas, beginning at about 14 weeks
|
• adenocarcinomas found in ampullary region of the pancreatic duct, incomplete penetrance
|
• in 53% of mice older than 10 weeks, skin epidermoid cysts found in left axillary region and/or ventral side of the neck
|
• adenocarcinomas found in ampullary region of the pancreatic duct, incomplete penetrance
|
• in 53% of mice older than 10 weeks, skin epidermoid cysts found in left axillary region and/or ventral side of the neck
|
• polyps in small and large intestine develop into malignant adenocarcinomas, beginning at about 14 weeks
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
colorectal cancer | DOID:9256 |
OMIM:114500 |
J:46242 |
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• the number and size distribution of small intestinal polyps is not different from mice heterozygous for Apctm1Mmt alone
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/17/2024 MGI 6.24 |
|
|